Scientists Unveil The World’s First Antimicrobial Medical Gloves
British researchers now present the world’s first medical gloves designed to prevent the spread of infection. This novel medical examination glove has built in antimicrobial technology proven to prevent the spread of infection.
Professor Emeritus Richard James working with medical glove makers Hartalega Malaysia and antimicrobial research and development company Chemical Intelligence UK has now revealed these the new gloves that are the first non-leaching antimicrobial medical gloves in the world.
The team eventually expects to sell in their billions as healthcare organisations strive to fight infection and combat antimicrobial resistance.
The gloves will be the first to include a new active microorganism-killing molecule made to protect against the spread of germs to and from people and surfaces. Since the technology is built into the substance, the gloves do not require surface applications of additional compounds or solutions.
In independent testing, the glasses attained around a 99.9% kill inside only five minutes of touch. Part of this testing was completed at the University of Nottingham’s Centre for Biomolecular Science in the Advanced Microscopy Unit.
Professor James said: “These gloves will be a game-changer for the healthcare industry, both public and private. I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future.”
Mr Kuan Mun Leong, Managing Director of Hartalega Holdings Berhad, said: “In the European Union alone, cross-contamination in hospitals results in 37,000 deaths a year at an additional cost of 7 billion euros. By renovating a medical device that has not been remodelled in over 30 years, our innovation is set to make waves in the healthcare industry and save lives across the globe.”
Founder of Chemical Intelligence UK, Rob Gros said of the partnership: “After years of development, we are delighted to finally release this product to market and truly believe it will make a significant difference in the fight against healthcare associated infections (HAIs). Like Hartalega, we have a passion for innovation and together we are the perfect partners to release this technology.”